MEXICO CITY (Reuters) - Mexican President Andres Manuel Lopez Obrador said on Wednesday the country has “other options” for a potential COVID-19 vaccine after drugmaker AstraZeneca Plc suspended a late-stage trial due to an illness in a participant.
The governments of Argentina and Mexico have agreed to produce the AstraZeneca COVID-19 vaccine for most of Latin America. Mexico is in talks with several companies about vaccine trials.
Reporting by Daina Beth Solomon
Our Standards: The Thomson Reuters Trust Principles.